Gastrointestinal health startup Geneoscopy wants more people to get screened for colorectal cancer. Since getting approval from the U.S. Food and Drug Administration in the past year, the firm has begun commercializing its test for the disease, called ColoSense. First founded in 2015, it also concluded a $105 million Series C funding round in January…
